These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. Bannas P, Kramer H, Hernando D, Agni R, Cunningham AM, Mandal R, Motosugi U, Sharma SD, Munoz del Rio A, Fernandez L, Reeder SB. Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591 [Abstract] [Full Text] [Related]
5. Evaluation of hepatic steatosis before liver transplantation in ex vivo by volumetric quantitative PDFF-MRI. Chen G, Jiang J, Wang X, Yang M, Xie Y, Guo H, Tang H, Zhou L, Hu D, Kamel IR, Chen Z, Li Z. Magn Reson Med; 2021 May; 85(5):2805-2814. PubMed ID: 33197060 [Abstract] [Full Text] [Related]
8. Detection of Liver Steatosis With a Novel Ultrasound-Based Technique: A Pilot Study Using MRI-Derived Proton Density Fat Fraction as the Gold Standard. Ferraioli G, Maiocchi L, Raciti MV, Tinelli C, De Silvestri A, Nichetti M, De Cata P, Rondanelli M, Chiovato L, Calliada F, Filice C. Clin Transl Gastroenterol; 2019 Oct; 10(10):e00081. PubMed ID: 31609745 [Abstract] [Full Text] [Related]
9. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease. Paige JS, Bernstein GS, Heba E, Costa EAC, Fereirra M, Wolfson T, Gamst AC, Valasek MA, Lin GY, Han A, Erdman JW, O'Brien WD, Andre MP, Loomba R, Sirlin CB. AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360 [Abstract] [Full Text] [Related]
14. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, Ajmera V, Bettencourt R, Collier S, Hooker J, Sy E, Rizo E, Richards L, Sirlin CB, Loomba R. Hepatology; 2018 Apr; 67(4):1348-1359. PubMed ID: 29108123 [Abstract] [Full Text] [Related]
15. Multiparametric ultrasound imaging for early-stage steatosis: Comparison with magnetic resonance imaging-based proton density fat fraction. Baek J, Basavarajappa L, Margolis R, Arthur L, Li J, Hoyt K, Parker KJ. Med Phys; 2024 Feb; 51(2):1313-1325. PubMed ID: 37503961 [Abstract] [Full Text] [Related]
16. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis. Wildman-Tobriner B, Middleton MM, Moylan CA, Rossi S, Flores O, Chang ZA, Abdelmalek MF, Sirlin CB, Bashir MR. Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769 [Abstract] [Full Text] [Related]
17. Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis. Gu J, Liu S, Du S, Zhang Q, Xiao J, Dong Q, Xin Y. Eur Radiol; 2019 Jul; 29(7):3564-3573. PubMed ID: 30899974 [Abstract] [Full Text] [Related]
18. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A. Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985 [Abstract] [Full Text] [Related]